48576UAA4
Karyopharm Therapeutics Inc.
Could not find a ticker for this position, may be a filing error
A biopharmaceutical company that makes cancer drugs, best known for XPOVIO (selinexor), an oral pill for blood cancers like multiple myeloma and lymphoma. Its medicines work by a novel mechanism that blocks a protein from shuttling tumor-suppressor proteins out of the cell nucleus, letting them do their job. Founded in 2008 by Dr. Sharon Shacham, a cancer researcher, and Dr. Michael Kauffman, the company's name blends the Greek word "karyon" (nucleus) with "pharm" — a nod to its nuclear-targeting science.
CONVERTIBLEUnderlying: KPTIEURCUSIP: 48576UAA4HealthcareUS1 derivative reporter
3.00% Convertible Senior Notes Due 2025
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
